Ontology highlight
ABSTRACT: Background
Universal access to high quality essential medicines is critical to sustainable development (SDG 3.8). However low- and middle-income countries struggle to ensure access to all medicines on their national essential medicines lists (EML). Market registration is the first step in determining both access and availability yet the extent to which essential medicines are registered for use at country level is not known. Companies apply for a marketing authorisation, however low price or lack of a market is a disincentive. Local production has been promoted to ensure availability of essential medicines but research in this area is also limited.Methods
The study took place between 2011 and 2015. We systematically examined the registration status of medicines and vaccines
SUBMITTER: Brhlikova P
PROVIDER: S-EPMC7419186 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature